Validations: Data Trending, OOT/OOS Analytics
OOT Triggers: Statistical vs Visual Rules OOT Triggers: Statistical vs Visual Rules In the pharmaceutical industry, ensuring the integrity of products throughout their shelf-life is paramount. Stability studies, a core component of product development and regulatory compliance, utilize various strategies to manage the quality of pharmaceutical products. This comprehensive guide focuses on Out Of Trend (OOT) triggers, shedding light on…
OOS Investigations: Narrative That Survives Audit OOS Investigations: Narrative That Survives Audit In the field of pharmaceutical development, ensuring compliance with regulatory guidelines while maintaining product integrity is paramount. Out-of-Specification (OOS) investigations are crucial components of this quality assurance framework. This article aims to provide a step-by-step tutorial guide for conducting OOS investigations that withstand scrutiny during audits. We will…
Attribute-Specific Trending: Assay, Degradants, and Dissolution Attribute-Specific Trending: Assay, Degradants, and Dissolution Introduction In the field of pharmaceutical development, ensuring the stability of drug products is critical for compliance and efficacy. A robust stability program must incorporate effective trending analytics for assay, degradants, and dissolution characteristics of pharmaceutical products. This article serves as a step-by-step tutorial on harnessing trending methodologies…
Biologics Stability Trends: Potency, Aggregates, and Charge Stability testing is a critical component in the lifecycle management of biologics. The U.S. Food and Drug Administration (FDA), European Medicines Agency (EMA), and Medicinal Healthcare Regulatory Agency (MHRA) have established stringent guidelines governing the stability of biologics. In compliance with ICH Q1A(R2) and ICH Q1E, this guide outlines the essential elements necessary…
Photostability Trends: When and How to Use Photostability Trends: When and How to Use The design and implementation of a stability program are critical components in the pharmaceutical development lifecycle, influencing regulatory submissions and market readiness. This step-by-step tutorial will address key aspects of stability program scale-up, focusing on global protocol harmonization, portfolio bracketing and matrixing, chamber qualification strategy, and…